The DOI matches its Crossref record; 219 of the 220 references it cites were found in a registry or an index.
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
Open accessAbstract
Cancer represents a group of heterogeneous diseases characterized by uncontrolled growth and spread of abnormal cells, ultimately leading to death. Nanomedicine plays a significant role in the development of nanodrugs, nanodevices, drug delivery systems and nanocarriers. Some of the major issues in the treatment of cancer are multidrug resistance (MDR), narrow therapeutic window and undesired side effects of available anticancer drugs and the limitations of anticancer drugs. Several nanosystems being utilized for detection, diagnosis and treatment such as theranostic carriers, liposomes, carbon nanotubes, quantum dots, polymeric micelles, dendrimers and metallic nanoparticles. However, nonbiodegradable nanoparticles causes high tissue accumulation and leads to toxicity. MDR is considered a major impediment to cancer treatment due to metastatic tumors that develop resistance to chemotherapy. MDR contributes to the failure of chemotherapies in various cancers, including breast, ovarian, lung, gastrointestinal and hematological malignancies. Moreover, the therapeutic efficiency of anticancer drugs or nanoparticles (NPs) used alone is less than that of the combination of NPs and anticancer drugs. Combination therapy has long been adopted as the standard first-line treatment of several malignancies to improve the clinical outcome. Combination therapy with anticancer drugs has been shown to generally induce synergistic drug actions and deter the onset of drug resistance. Therefore, this review is designed to report and analyze the recent progress made to address combination therapy using NPs and anticancer drugs. We first provide a comprehensive overview of the angiogenesis and of the different types of NPs currently used in treatments of cancer; those emphasized in this review are liposomes, polymeric NPs, polymeric micelles (PMs), dendrimers, carbon NPs, nanodiamond (ND), fullerenes, carbon nanotubes (CNTs), graphene oxide (GO), GO nanocomposites and metallic NPs used for combination therapy with various anticancer agents. Nanotechnology has provided the convenient tools for combination therapy. However, for clinical translation, we need continued improvements in the field of nanotechnology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Historically, drug combinations have been utilized efficiently to treat various bacterial and viral infections and to fight cancer [18–21].”
From Aprepitant, an antiemetic agent, interferes with metal ion homeostasis of Candida auris and displays potent synergistic interactions with azole drugs (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yuan, Y., Peng, Q., & Gurunathan, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s136142 · Cited by 52
Self-citationRetractedJemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S. M., Négrier, S., Szczylik, C. A., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,752
Global patterns and trends in colorectal cancer incidence and mortality
Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2016) · Gut · doi:10.1136/gutjnl-2015-310912 · Cited by 5,392
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B. J., Eisen, T. G., Stadler, W. M., Szczylik, C. A., Oudard, S. M., Siebels, M., Négrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,854
Flagged first, then by citations
1 of the 220 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Mewani, 2004, Analysis of gene expression in breast cancer cells treated with antisense raf oligonucleotide using microarray, Proc. Am. Assoc. Cancer Res., 64, 1209
Cited by
Sorted by citations
Items 301–367 of 367
Advances in biomimetic nanomaterials for targeted drug delivery in colon cancer
Dharme, K. K., Jain, P., Verma, G., & Uddin, A. (2026) · Holistic Integrative Oncology · doi:10.1007/s44178-026-00279-4 · Cited by 1
Skin Cancer Treatment with Emphasis on Nanotechnology
Murugan, B. (2021) · Springer eBooks · doi:10.1007/978-981-16-0364-8_11 · Cited by 1
Advanced nanomaterial for point-of-care chemotherapy
Panda, S. S., Das, H., Panda, S. P., Kolluri, S., & Kilaru, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85725-3.00006-4 · Cited by 1
Green synthesis of silver nanoparticles, characterization techniques and biological activities
Kher, M. N., Dholakia, S. P., Sureja, D. K., Bhatt, V. D., & Patel, N. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15457-7.00006-x · Cited by 1
Magnetically Controlled Hyaluronic Acid–Maghemite Nanocomposites with Embedded Doxorubicin
Spiridonov, V. V., Zoirova, Z., Alyokhina, Y., Perov, N. S., Afanasov, M. I., Pozdyshev, D. V., Krjukova, D., Knotko, A. V., Muronetz, V. I., & Yaroslavov, A. A. (2023) · Polymers · doi:10.3390/polym15173644 · Cited by 1
Organic Nanomaterials Loaded with Cytotoxic Agents: A Therapeutic Alternative Against Cancer
Mejía-Méndez, J. L., López-Mena, E. R., Navarro-López, D. E., Sánchez-Arreola, E., & Cerro‐López, M. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_267 · Cited by 1
Thakur, S., & Mandava, K. (2024) · Asian Journal of Chemistry · doi:10.14233/ajchem.2024.31226 · Cited by 1
Kumar, P., Singh, A., Sarkar, N., & Kaushik, M. (2024) · Materials Today Communications · doi:10.1016/j.mtcomm.2024.110775 · Cited by 1
Application of Nanocarrier Systems in Cancer Treatment
Reihani, N., Atrooz, O. M., Mozafari, M. R., & Taghavi, E. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_478 · Cited by 1
Navigating Infectious Challenges: The Nanomedicine Era
Sherilraj, P. M., Arora, K., Abutwaibe, K. A., Javaid, A., & Mudavath, S. L. (2024) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-72467-1_12 · Cited by 1
Nanoparticulate systems for combination therapies of lung cancer: A review
Moradi, A., Maskoukian, S., Bączek, T., Rabiee, N., Saeb, M. R., Farokhi, M., & Mottaghitalab, F. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06233-1 · Cited by 1
Rejili, M., Farahani, N., Alimohammadi, M., & Hushmandi, K. (2026) · Discover Oncology · doi:10.1007/s12672-026-05260-1 · Cited by 1
Formulation and Evaluation of Bendamustine Loaded Polymeric Nanoparticle
Telsang, M., Pradeep, D., Wilson, B., Tamreen, V., Sadik, S., Habeebuddin, M., Asif, A. H., Asdaq, S. M. B., Nagaraja, S. H., & Noor, S. D. (2022) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.56.2.61 · Cited by 1
Shaikh, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-9535-3_12 · Cited by 1
Qian, X., Xia, C., Chen, X., Li, Q., & Li, D. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2100024 · Cited by 1
Theranostic Approaches for Diagnosis and Treatment of Cancer: An Update
Ali, R., Ahmed, F., & Chauhan, M. K. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_18 · Cited by 1
Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy
Sakthivel, S., Srivastava, M., Barman, M. K., Ravichandiran, N., Martins, S., Singh, M. M., Chand, K., Sonkar, S. C., & Bhukya, P. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-6530-8.ch017
Polymeric nanocarriers for delivery of combination drugs
Narang, J. K., Dogra, A., Ali, J., Baboota, S., & Narang, R. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820779-6.00007-4
Therapeutic implications of inorganic nanoparticles for codelivery of bioactives in cancer therapy
Lather, V., Awasthi, R., Poonia, N., Kalonia, H., & Pandita, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820779-6.00001-3
Therapeutic potential of zein-based nanoparticles
Reboredo, C. (2022) · doi:10.15581/10171/62894
Tracking and analysis of movement at different scales
Georgopoulou, D. G. (2020) · doi:10.23889/suthesis.59732
(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac131.095
Nanocarriers for Smart Therapeutic Strategies to Treat Drug-Resistant Tumors: A Review
Alqahtani, A. A., Aslam, H., Shukrullah, S., Fatima, H., Naz, M. Y., Rahman, S., Mahnashi, M. H., & Irfan, M. (2022) · Assay and Drug Development Technologies · doi:10.1089/adt.2022.025
Janković, S., Cazic, M., Janić, D., Lazić, J., Rodić, P., & Krstovski, N. (2022) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh221028119j
Progress of Cancer Nano Medicine, Clinical Hurdles, and Opportunities
Tagde, P., Sharma, A., Goyal, K., & Jindal, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-5558-7_3
Nanotheranostic Approach for Cancer Treatment
Ahmad, M. Z., Pathak, K., Bhatnagar, D., Ladhe, S., Kumar, D., Saikia, R., & Das, A. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_296-1
Hadavi, K., & Oroojalian, F. (2022) · Journal of North Khorasan University of Medical Sciences · doi:10.32592/nkums.15.2.61
Combination of Photothermal Therapy with Magnetic Hyperthermia Therapy
(2023) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781837672226-00221
Nanoparticles Based on Silver Chloride and Bambusuril[6] for the Fine-Tuning of Biological Activity
Turebayeva, P., Luchsheva, V., Fedorishin, D. A., Yerkassov, R., Бакибаев, А. А., Bolysbekova, S. M., Tugambayeva, T., Мубараковна, С. С., & Nurmukhanbetova, N. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216126 · Cited by 2
Microencapsulation of Doxorubicin Using Chitosan
Puertas, J., López, A., Cazorla, F. G., Labrador, M. G., Baubin, M. A. R., & Arias, M. J. L. (2023) · Drug Delivery Letters · doi:10.2174/0122103031255282231117053143
Dzvairo, T., & Kapfunde, A. (2023) · Journal of Tertiary Education and Learning · doi:10.54536/jtel.v1i3.2261
Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy
Sakthivel, S., Srivastava, M., Barman, M. K., Ravichandiran, N., Martins, S., Singh, M. M., Chand, K., Sonkar, S. C., & Bhukya, P. (2023) · IGI Global eBooks · doi:10.4018/979-8-3693-3026-5.ch020
Soto, K. M., López-Romero, J. M., Mendoza-Díaz, S., Mendez, N. E., & Manzano-Ramírez, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13937-6.00003-2
Applications of Tissue Engineering
Sooriyaperakasam, N. (2024) · Journal of Computers Mechanical and Management · doi:10.57159/gadl.jcmm.3.3.240124
Abdel-Wahhab, M. A., El‐Nekeety, A. A., Salman, A. S., Hamza, Z. K., Akl, E. M., Aly, S. E., & Kang, W. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250374
Bibi, N., & Yasmin, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-6948-3_3
Karišik, M. J., Jović, N., Čarkić, J., Lazarević, M. M., Mitić, D., Jokanović, B., Jokanović, V., & Milašin, J. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16030109
Refractory and Relapsed Neuroblastoma: Exploring New Treatment Methods to Improve Outcomes
Abbas, A. (2025) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-025-02311-x
Liu, H., Liu, Q., Li, X., Boucetta, A., Eyer, J., & Spadavecchia, J. (2025) · Nanotheranostics · doi:10.7150/ntno.109280
Exploring Microbial Nanomaterials for Novel Cancer Therapies
Mistri, A., Chatterjee, P., & Sardar, S. (2025) · Materials horizons · doi:10.1007/978-981-96-8923-1_7
Song, R., Li, B., Gao, C., Yang, Z., Zhu, T., Sun, Y., Sheng, H., & Zhu, L. (2025) · Current Drug Delivery · doi:10.2174/0115672018405334250831225746
Nanotheranostic Approach for Cancer Treatment
Ahmad, M. Z., Pathak, K., Bhatnagar, D., Ladhe, S., Kumar, D., Saikia, R., & Das, A. (2025) · Springer eBooks · doi:10.1007/978-3-032-00773-5_296
Nanocrystals Applications in Cancer Therapy
Mukherjee, S., Madamsetty, V. S., Reddy, R., Pradhan, L., Yenurkar, D., Manna, S., & Banerjee, D. (2025) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-032-04133-3_3
Sharma, S., Dkhar, B., Majau, A. B., Panda, J., Al-Sehemi, A. G., & Bhuyan, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26761-1.00002-8
Innovative approaches of metallic (gold and silver) nanoparticles in targeting of prostate cancer
Soundarya, R., Gunasekaran, S. K., Gobinath, M., Kapoor, D. U., Gobinath, M., & Nivedhitha, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33208-1.00013-5
Targeted Nanoparticles: an Innovative Modality in the Treatment of CancerPreprint
Kang, H., Upton, B., Holly, R. W., Upton, R., Mitra, S. A., Parmentier, J., Mohrbacher, A., Kim, Y., Triche, T. J., & Nagy, J. O. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.01.691687
Park, J.-Y., Lee, G.-H., Yoo, K. H., & Khang, D. (2024) · Figshare · doi:10.6084/m9.figshare.26560931
Misiak, P., Niemirowicz-Laskowska, K., Markiewicz, K. H., Wielgat, P., Kurowska, I., Czarnomysy, R., Misztalewska‐Turkowicz, I., Car, H., Bielawski, K., & Wilczewska, A. Z. (2024) · Figshare · doi:10.6084/m9.figshare.26576246
Medical Nanoparticles: Breakthroughs in Diagnostics and Targeted Therapies
Mabsor-Zgandaoui, S., Rachmoune, K., Boulmane, H., Dakir, H., Aftais, I., Ettayri, K., Hamdan, Y. A., Zgandaoui, Y., & Moutaouakkil, A. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch003
Gharehbaba, M. A., Soleimani, M., & Jafari, S. (2025) · Journal of Polymer Research · doi:10.1007/s10965-025-04714-4
DENDRIMERS: ADVANCEMENTS IN NOVEL DRUG DELIVERY SYSTEM
KHALADKAR, S. V., RAHATAL, R. A., Mhetre, R. L., Kulkarni, N., & Dhole, S. N. (2026) · Innovare Journal of Medical Sciences · doi:10.22159/ijms.2026v14i1.56453
Cancer Nanomedicine: Trends and Future Perspectives
Balkrishna, A., Kumari, A., Jeet, A., Srivastava, D., Sharma, H., Arya, V., Kumar, A., Loveleen, L., Kumari, R., Nimesh, S., et al. (2026) · Springer eBooks · doi:10.1007/978-981-95-6714-0_11
Targeting methylation and acetylation in colon cancer
Gopathy, S., Lakshmanan, D., AROCKYASAMY, A. S., Srividya, S., & Bhavani, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27765-8.00006-0
Current Advances in Nanobiomaterials as Nanomedicine for Oncology
Ranjan, N., Lata, P., Tanaya, S., Raturi, A., Jha, V., Shekhar, S., Raj, R., Parthsarthi, D., & Kumari, A. (2026) · Springer eBooks · doi:10.1007/978-981-95-5589-5_9
Narmadha, R., Keerthana, S. V., Kala, K., Govindan, R., & Kannan, M. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.102276
Nanomedicine in cancer care: Unmasking the hidden toxicological shadows
Vandana, K., Singh, R., Chauhan, S., Verma, D., Singh, S., Srivastava, E., Singh, A., & Gupta, P. K. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108533
Alkhudhayri, A. A., & Alanazi, A. D. (2026) · Vector-Borne and Zoonotic Diseases · doi:10.1177/15303667261469042
Fathali, F., Taravati, A., & Tafrihi, M. (2026) · 3 Biotech · doi:10.1007/s13205-026-04964-z
Patel, S., Sharma, S., Verma, S., Mishra, P., & Kumar, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-9386-6_8
Fadel, E., & Eissa, M. M. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00380
Gayathri, S., Riyas, Z. M., & Christy, A. J. (2026) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2026.103029
Joo, K. S., Kwon, I. A., Park, J.-Y., & Khang, D. (2026) · Materials Today Nano · doi:10.1016/j.mtnano.2026.100941
Silva, L., Rahaman, W., Ali, S., Gedda, L., Hernández, V. A., & Edwards, K. (2026) · Journal of Liposome Research · doi:10.1080/08982104.2026.2738451
Converging Nanotechnology and Artificial Intelligence for Translational Cancer Theranostics
Kanaujia, K. A., Kumar, B. V., Meher, N., Ahmad, A., & Saraf, S. A. (2026) · BioNanoScience · doi:10.1007/s12668-026-02912-y
Metadata
- Authors
- Gurunathan, S., Kang, M.-H., Qasim, M., & Kim, J.-H.
- Affiliations
- Konkuk University (KR)
- Corresponding author
- Gurunathan, Sangiliyandi
- Kim, Jin-Hoi
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-20
- Volume
- 19
- Issue
- 10
- Pages
- 3264
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6214025
- OpenAlex
- W2896053285
- Cited by
- 367
- References
- 220
- Citations by year
- 2026: 26 · 2025: 55 · 2024: 55 · 2023: 51 · 2022: 57 · 2021: 52 · 2020: 47 · 2019: 24
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- cancer nanomedicine, multidrug resistance, anticancer drug delivery, liposomes, polymeric micelles, dendrimers, carbon nanotubes, graphene oxide, nanodiamonds, C60, metal nanoparticles, angiogenesis, theranostic nanocarriers, drug synergy
- MeSH terms
- Animals, Antineoplastic Agents, Drug Therapy, Combination, Humans, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
